Table 6.
Questionnaire-based outcome measures
| Outcome | 3 Months | 6 Months | ||
|---|---|---|---|---|
| Adjusted mean diff. between groups (95% CI) | P Value | Adjusted mean diff. between groups (95% CI) | P Value | |
| Quality of life | ||||
| EQ-5D Index Score | 0.02 (−0.04, 0.1) | 0.6 | 0.1 (−0.01, 0.1) | 0.1 |
| ED-5D VAS | 1 (−4, 7) | 0.7 | −1 (−6, 4) | 0.7 |
| FACT-P | ||||
| Physical WB | 0.8 (−0.4, 2.0) | 0.2 | 0.2 (−0.9, 1.3) | 0.8 |
| Social WB | 1.2 (−0.4, 2.8) | 0.1 | −2.4 (−8.3, 3.5) | 0.4 |
| Emotional WB | −0.7 (−1.9, 0.6) | 0.3 | 1.1 (−0.1, 2.3) | 0.08 |
| Functional WB | 1.9 (0.3, 3.5) | 0.02 | 1.9 (0.01, 3.8) | 0.04 |
| Prostate cancer specific | 2.3 (1.0, 3.7) | <0.01 | 3.1 (1.3, 5.0) | <0.01 |
| FACT-P TOI | 5.0 (1.9, 9.1) | <0.01 | 5.0 (1.8, 8.3) | <0.01 |
| FACT-P Total Score | 5.3 (0.7, 9.8) | 0.03 | 4.2 (−1.6, 10.1) | 0.2 |
| FACT-G Total Score | 3.1 (−0.8, 7.0) | 0.1 | 0.9 (−4.0, 5.7) | 0.7 |
| Fatigue | ||||
| BFI | −0.5 (−1.3, 0.3) | 0.3 | −0.1 (−0.9, 0.6) | 0.7 |
| Godin Leisure Time Exercise Questionnaire (modified) | ||||
| VA frequency (days/week) | 0.1 (−0.4, 0.7) | 0.7 | 0.4 (−0.1, 0.9) | 0.2 |
| VA duration (mins/session) | −27.2 (−66.3, 11.9) | 0.2 | −3.2 (−14.2, 7.8) | 0.6 |
| MIA frequency (days/week) | 0.2 (−1.2, 1.6) | 0.8 | 0.3 (−0.9, 1.5) | 0.6 |
| MIA duration (mins/session) | 22.1 (4.1, 40.0) | 0.02 | 16.9 (−8.1, 42.0) | 0.2 |
| LIA frequency (days/week) | −1.0 (−2.4, 0.4) | 0.2 | −0.7 (−2.2, 0.8) | 0.4 |
| LIA duration (mins/session) | −10.4 (−33.9, 13.2) | 0.4 | 3.4 (−24.1, 30.9) | 0.8 |
| RET frequency (days/week) | 2.6 (1.8, 3.5) | <0.01 | 1.9 (1.0, 2.9) | <0.01 |
| RET duration (mins/session) | 27.8 (20.7, 35.0) | <0.01 | 17.4 (10.8, 24.0) | <0.01 |
CI confidence interval, VAS visual analogue scale, WB well-being, TOI trial outcome index, VA vigorous aerobic activity, MIA moderate intensity aerobic activity, LIA low-intensity aerobic activity, RET resistance exercise training. Statistical significance: P<0.05